Keyphrases
All-cause Mortality
100%
Evidence-based Treatment
100%
Acute Myocardial Infarction
100%
Confidence Interval
80%
Hazard Ratio
80%
Evidence-based
40%
Non-adherence
40%
Survivors
40%
Mortality Risk
40%
Combined Therapy
40%
Angiotensin-converting Enzyme Inhibitor (ACEi)
40%
Medication Nonadherence
40%
Cardioprotective Medications
40%
Proportion of Days Covered
40%
Angiotensin Receptor Blockers
40%
Israel
20%
Cox Proportional Hazards Model
20%
High Risk
20%
Risk Increase
20%
Clinical Characteristics
20%
Mortality Hazard
20%
Aspirin
20%
Statins
20%
Patient-centered
20%
Health Organizations
20%
Heart Failure Patients
20%
Heart Failure
20%
Increasing Risk
20%
Ischemic Heart Disease
20%
Survival Benefit
20%
Retrospective Cohort Study
20%
Patient Demographic Characteristics
20%
Beta-blockers
20%
Aspirin Therapy
20%
Statin Therapy
20%
Patient Subgroups
20%
Dose-response Gradient
20%
Multidrug
20%
Failure Hazard
20%
Single Component
20%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
100%
Acute Heart Infarction
100%
Acetylsalicylic Acid
40%
Dipeptidyl Carboxypeptidase Inhibitor
40%
Angiotensin Receptor Antagonist
40%
Ischemic Heart Disease
20%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Statin (Protein)
20%
Cohort Study
20%
Congestive Heart Failure
20%
Beta Adrenergic Receptor Blocking Agent
20%